0001921810-22-000001.txt : 20220502
0001921810-22-000001.hdr.sgml : 20220502
20220502120119
ACCESSION NUMBER: 0001921810-22-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Section 3(c)(1)
FILED AS OF DATE: 20220502
DATE AS OF CHANGE: 20220502
EFFECTIVENESS DATE: 20220502
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: 3D Bio Therapeutics, a Series of VUVP Fund I, LLC
CENTRAL INDEX KEY: 0001921810
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-444034
FILM NUMBER: 22880334
BUSINESS ADDRESS:
STREET 1: PO BOX 171305
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84117
BUSINESS PHONE: (801) 419-0677
MAIL ADDRESS:
STREET 1: PO BOX 171305
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84117
D
1
primary_doc.xml
X0708
D
LIVE
0001921810
3D Bio Therapeutics, a Series of VUVP Fund I, LLC
6510 S Millrock Drive
Suite 400
Salt Lake City
UT
UTAH
84121
(801) 419-0677
DELAWARE
None
None
Limited Liability Company
true
2022
LLC
Assure Fund Management II
PO Box 171305
Salt Lake City
UT
UTAH
84117
Director
Issuer's Manager
Richard
Thoms
PO Box 171305
Salt Lake City
UT
UTAH
84117
Executive Officer
Officer of the Issuer's Manager
Jeremy
Neilson
PO Box 171305
Salt Lake City
UT
UTAH
84117
Executive Officer
Managing Director of the Issuer's Manager
Pooled Investment Fund
Other Investment Fund
false
Decline to Disclose
- 06b
- 3C.1
false
2022-04-26
false
true
false
5000
316600
316600
0
false
35
0
0
8000
This amount represents a one-time cost to cover fund organizational and operating expenses.
3D Bio Therapeutics, a Series of VUVP Fund I, LLC
Richard Thoms
Richard Thoms
Officer of the Issuer's Manager
2022-04-27